- Home
- GLBS vs ANTX Comparison
GLBS vs ANTX Comparison
Compare GLBS & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLBS | ANTX |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.0M | 31.2M |
| IPO Year | 2007 | 2022 |
Fundamental Metrics
Financial Performance| Metric | GLBS | ANTX |
|---|---|---|
| Price | $1.57 | $1.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $3.00 | $2.00 |
| AVG Volume (30 Days) | 33.6K | ★ 131.5K |
| Earning Date | 03-13-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,444,000.00 | N/A |
| Revenue This Year | $24.03 | N/A |
| Revenue Next Year | $13.92 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.49 | N/A |
| 52 Week Low | $0.99 | $1.00 |
| 52 Week High | $1.99 | $1.55 |
Technical Indicators
Market Signals| Indicator | GLBS | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 41.90 | 42.47 |
| Support Level | $1.65 | $1.05 |
| Resistance Level | $1.67 | $1.18 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 16.00 | 13.04 |
Price Performance
Historical ComparisonAbout GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.